Tag: <span>β-AR agonist therapy</span>

Home / β-AR agonist therapy
β-AR agonist therapy puts the brakes on oral cancer progression
Post

β-AR agonist therapy puts the brakes on oral cancer progression

TOKYO MEDICAL AND DENTAL UNIVERSITY IMAGE: IN THIS STUDY WE IDENTIFIED ISOXSUPRINE, A Β2-ADRENERGIC RECEPTOR AGONIST AS AN EFFECTIVE INHIBITOR OF MESENCHYMAL PHENOTYPES AND MIGRATION OF ORAL SQUAMOUS CELL CARCINOMA CELLS SUGGESTING THAT Β2-ADRENERGIC RECEPTOR SIGNAL. CREDIT: DEPARTMENT OF BIOCHEMISTRY,TMDU Researchers from Tokyo Medical and Dental University (TMDU) find that stimulating a group of cellular...